OR13Z2P

Across TCGA pan-cancer cohorts, OR13Z2P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR13Z2P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher OR13Z2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR13Z2P expression acts as an unfavorable survival marker, although some lineages such as OV and UCEC show a favorable association.

DLBC, LIHC, and THCA are the cancer types where OR13Z2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.053	0.936	<.001	33	view →
LIHC	OS	Quartile	All	0.252	0.522	.007	33	view →
THCA	DFS	Tertile	III,IV	0.228	0.757	.015	21	view →
KICH	OS	Tertile	All	0.920	0.984	.044	12	view →
CESC	DFS	Tertile	II,III,IV	0.234	0.544	.042	12	view →
ACC	OS	Tertile	All	0.252	0.668	.006	12	view →
OV	DFS	Quartile	IV	0.545	0.309	.033	10	view →
GBM	DFS	Tertile	All	0.111	0.263	.009	9	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
LGG	OS	Tertile	All	0.363	0.801	.011	9	view →
UCEC	OS	Quartile	IV	0.736	0.344	.035	8	view →
READ	OS	Quartile	IV	0.878	0.470	.024	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR13Z2P–DLBC (OS)

Open the DLBC breakdown →